Fig. 8: Schematic representation of the mechanism via which denosumab attenuates OA progression by inhibiting RANK/TRAF6/FSTL1 signalling in FLSs.
FLSs fibroblast-like synoviocytes. CHO chondrocytes.
Fig. 8: Schematic representation of the mechanism via which denosumab attenuates OA progression by inhibiting RANK/TRAF6/FSTL1 signalling in FLSs. | Nature Communications
